Introduction
Cancer development and progression are suggested to be linked to the host's systemic inflammatory response (1) (2) (3) . While rationales remain controversial, inflammatory-based laboratory indices have been identified as predictive indicators for several tumors. The neutrophil-to-lymphocyte ratio (NLR) is one of the most common hematologic parameters reflecting global inflammation with a prognostic value for survival in patients with various solid malignancies. Elevated NLR as a pretreatment term has been proposed to be an adverse prognostic factor in colorectal cancer (4, 5) , hepatocellular carcinoma (6, 7) , pancreatic cancer (8, 9) , renal cell carcinoma (10) , breast cancer (11) and esophagogastric cancer (12) (13) (14) (15) (16) (17) . As mentioned in a representative review by Templeton et al. (18) , most such studies, with a few exceptions (11) (12) (13) , employed pretreatment NLR as a categorical variable, dividing patients into two groups with arbitrary cut-off values for NLR and compared their post-treatment outcomes. A dichotomous methodology is by nature based on the postulation that the relationship between mortality and pretherapeutic NLR can be assumed to be monotonically linear or that NLR has a threshold effect on prognosis. In fact, however, previous retrospective studies have not sufficiently verified this assumption, and little is thus known about the modal pattern of the predictive impact of NLR.
Gastric cancer, one of the leading causes of cancer-related deaths worldwide (19) , is among the entities most frequently correlated with NLR as a predictive factor (13) (14) (15) (16) . However, methods of patient stratification for such analyses have yet to be established. We retrospectively examined the association between long-term outcome and preoperative NLR in patients with gastric cancer, stratifying them into four groups according to their NLR in an attempt to clarify whether or not the relationship between prognosis and pretreatment NLR is monophasic.
Patients and methods

Patient cohort
A total of 1880 consecutive patients underwent gastrectomy with regional lymph node dissection for gastric cancer at the University of Tokyo Hospital, Tokyo, between July 1999 and December 2014. Oral consent was obtained from each patient prior to blood tests. Patients with preoperative chemotherapy or chemoradiotherapy (n = 98), R1/R2 resection (n = 146), preoperative endoscopic resection (n = 153), synchronous malignancies (n = 58), hematological disorders, liver cirrhosis, inflammatory diseases or collagen diseases (n = 21), and/or a follow-up period of less than 6 months (n = 33) were excluded from this study. There were no emergency cases. Of the remaining 1371 patients, precise pathological information and data on preoperative NLR (in principle measured within a week before surgery) were available for 1335 (97.4%), and they were included and retrospectively reviewed in this analysis. Our protocol was approved by the ethics committee of the faculty of medicine, the University of Tokyo.
Clinicopathological data
Baseline NLR was calculated as the neutrophil count divided by the lymphocyte count. In this study, the disease staging was determined based on the seventh edition of the TNM classification, established by the Union for International Cancer Control (20) . Histopathological type was determined according to Lauren's classification (21 
Statistical analysis
Differences in categorical variables were compared employing the chi-squared test. Survival curves were depicted using the KaplanMeier functions with the log-rank test. Univariate prognostic significance of variables was determined by means of univariate Cox regression analysis. Multivariate Cox regression incorporated all variables with P < 0.05 on univariate analysis. Overall survival (OS) was defined as the interval from surgery to death from any cause. Relapse-free survival (RFS) was defined as the interval from surgery to recurrence of the primary cancer or death from any cause. All P values presented were two-tailed, and a difference was taken to be statistically significant at P < 0.05. Statistical analyses were all carried out using JMP Pro version 13.0.0 (SAS Institute, Cary, NC, USA) and SAS software version 9.4 (SAS Inc., Cary, NC, USA).
Results
Associations between clinicopathological factors and the quartiles of preoperative NLR
The preoperative NLR ranged from 0.15 to 24 in our cohort. The skewed frequency distribution of the NLR is illustrated in Fig. 1 . We divided the 1335 included patients into four strata using the quartiles of preoperative NLR as follows: Q1, NLR ≤ 1.59 (n = 334); Q2, 2.11 ≥ NLR > 1.59 (n = 334); Q3, 2.96 ≥ NLR > 2.11 (n = 334); Q4, NLR > 2.96 (n = 333). Associations between clinicopathological factors and Q1-Q4 are shown in Table 1 . Statistically significant differences were seen in relationships with categories of age, histological type, T stage (tumor depth), N stage (nodal metastasis), and the presence of adjuvant chemotherapy. Patients in the Q4 group were most likely to be older, to have an advanced stage cancer, and to have received adjuvant chemotherapy. 
Survival analysis for Q1-Q4 using Kaplan-Meier methods
At the time of the final follow-up, the median follow-up period in the 1335 included patients was 70.6 months. Survival times were calculated for Q1-Q4 with Kaplan-Meier estimates (Fig. 2) . With regards to both OS and RFS, overall P values (by log-rank test) were far below the level of significance. The Q4 curves indicated unfavorable outcomes as compared to the other three groups (Q1-3). Although NLR, neutrophil-to-lymphocyte ratio. *Statistically significant (P < 0.05). differences did not reach statistical significance, the Q2 curve appeared to show moderately prolonged survival as compared to those of Q1 and Q3.
Univariate and multivariate Cox regression analyses for OS and RFS
The univariate Cox regression analysis showed age, sex, histological type, T stage, N stage, presence of postoperative complications, presence of adjuvant chemotherapy and preoperative NLR (Q1-Q4) to be significantly associated with both OS and RFS (Table 2 ). In the following multivariate analysis for OS and RFS, preoperative NLR, as a tetrachotomous variable, did not lose its independence (P = 0.028, 0.023, respectively). Table 3 shows additional data, with the crude/adjusted hazard ratios with P values calculated from each combination of Q1-4 in univariate and multivariate analyses. When comparing Q1 with Q3 or Q4 in multivariate analysis, there were no significant differences in OS (P = 0.23, 0.37, respectively) and RFS (P = 0.26, 0.46, respectively). On the contrary, the difference between Q1 and Q2 approached significance for OS (hazard ratio 0.72, 95% confidence interval 0.49-1.06, P = 0.099) and reached significance for RFS (hazard ratio 0.69, 95% confidence interval 0.48-0.99, P = 0.048).
We redid multivariate Cox regression analyses for OS and RFS using data of quintiles (P1, NLR ≤ 1.48; P2, 1.87 ≥ NLR > 1.48; P3, 2.39 ≥ NLR > 1.87; P4, 3.20 ≥ NLR > 2.39; P5, NLR > 3.20). The result in case of pentasection implied a J-shaped association because the hazard of P2 seemed relatively lower than that of the others, especially with regards to RFS (data not shown).
Additionally, we conducted contrast testing for linear and J-shaped relationships between the adjusted hazard ratios of OS/ RFS among Q1-Q4 via CONTRAST STATEMENT of PHREG PROCEDURE using SAS software. Linear contrast test did not reveal significance regarding OS (Wald chi-square 1.03, P = 0.31) or RFS (Wald chi-square 1.03, P = 0.31). On the other hand, J-shaped contrast test assuming the hazard ratio is least in Q2 and highest in Q4 demonstrated statistical significance with regards to both OS (Wald chi-square 6.91, P = 0.009) and RFS (Wald chisquare 7.89, P = 0.005).
Causes of postoperative deaths
Mortality after surgery is shown in Fig. 3 . Postoperative deaths were most frequent in Q4, due to both recurrence and other diseases (n = 47, 44, respectively). There were fewer deaths from other diseases in Q2 than in the other groups. Table 4 provides detailed information on mortality from other diseases in groups Q1-Q4. The most common cause of mortality was other malignancies. Pneumonia and cardiovascular diseases were also major HR, hazard ratio; CI confidence interval; NLR, neutrophil-to-lymphocyte ratio. *Statistically significant (P < 0.05).
causes of postoperative deaths. Deaths from other malignancies were least frequent in Q2 (n = 5).
Discussion
We comparatively evaluated the postoperative survival times of four strata divided according to the quartiles of preoperative NLR (Q1-Q4) in 1335 patients with resectable gastric cancer. Although preoperative NLR showed an independent relationship with longterm surgical outcome overall in the four groups in multivariate Cox regression analysis, comparison between Q1 and Q3/Q4 showed no statistical prognostic difference, while comparison between Q1 and Q2 showed that RFS of Q1 group was significantly shorter than that of Q2 group (Tables 2 and 3 ). This result implied a J-shaped relationship with recurrence and preoperative NLR independent of other clinicopathological factors, which runs counter to the background assumption that the association between prognosis and NLR is linear in a monophasic mode or that the preoperative NLR has a threshold effect. If this is true, treating NLR as a dichotomous categorical variable in gastric cancer patients could overlook or underestimate the prognostic heterogeneity, shown in the present study, in this cohort. It is noteworthy that similar results were obtained in a large-scale retrospective study of patients with breast cancer (11) . The authors examined the prognostic value of pretreatment NLR, dividing 1435 patients into five strata based on the quintiles of NLR. Their pentachotomous Kaplan-Meier analysis revealed that patients in the second quintile showed relatively favorable post-treatment outcomes as compared to those in the first quintile (5-year relative survival, 79.4 vs. 76.4). Moreover, another previous study assessing prognostic significance of preoperative NLR in patients with gastric cancer also implied non-linear prognostic pattern (12) . Patients with medium NLR values (between 1.0 and 3.0) showed relatively better overall survival than those with the lowest NLR values (<1.0) in Kaplan-Meier estimates, supportively consistent with our result. We found the Q4 group (NLR > 2.96) to have markedly unfavorable outcomes as compared to the other groups, despite the presumed non-linear relationship between mortality and preoperative NLR as mentioned above. Several previous studies employed pretreatment NLR close to 2.96 as a cut-off value (4, 6, 7, 10, 15, 16, 18) . This approach might have unintentionally separated the population with the poorest prognosis in their cohorts (i.e. Q4 vs. Q1, Q2 and Q3), thereby demonstrating a significantly shorter survival time in a dichotomous analysis.
We can thus reasonably ask whether a method treating NLR as 'a continuous variable' is the best way to conduct prognostic evaluations. Considering the results obtained from the current study, we recommend caution when examining the effects of NLR as a continuous variable on long-term outcomes, because such an approach is also hypothetically based on the assumption of a monophasic linear relationship. In fact, a recent study on patients with bladder cancer, using clinical data from a large-scale randomized Phase 3 trial, demonstrated that pretreatment NLR, as a continuous variable, was neither a prognostic factor nor a predictive biomarker for OS in muscle-invasive bladder cancer (23) . In addition, pre-therapeutic NLR (as a continuous variable) was not independently related to long-term outcome in the multivariate Cox regression analysis in our prior publication focusing on patients with gastric and esophagogastric junction cancer (24) . It is difficult to explain why Q2 seemed to have a better prognosis than the other groups, as there have been few studies devoted to this issue. Reviewing causes of death in our cohort, the number of deaths from other diseases was the smallest in Q2 (Fig. 3) , probably contributing to the relatively favorable outcomes observed in this group. The most common cause of non-primary-disease deaths in the Q2 group was pneumonia, whereas other malignancy was the main cause of mortality in the other three groups (Table 4 ). This might imply that patients with a mid-range NLR score, neither very high nor very low, would be less susceptible to the development of other malignant tumors.
Some surgical and clinical factors are reported to be independent predictors of long-term outcome; for instance, postoperative complications (25, 26) and the sarcopenic status of patients (27) (28) (29) . No statistically significant differences were seen among Q1-Q4 in the incidence of complications in our study ( Table 1) . As for sarcopenic conditions, we assessed the skeletal muscle index calculated using pretreatment abdominal computed tomography images in 119 patients (operated in 2012-14). Differences in preoperative skeletal muscle indices among Q1-3 were minimal, while the index of the Q4 group tended to be lower than those of the other groups (data not shown). Taken together, these observations indicate that neither complications nor sarcopenia can explain the relatively favorable prognosis of the Q2 group.
Other factors possibly influencing patients' NLR scores include their background diseases. For example, common diseases, such as liver cirrhosis (excluded from our cohort), can result in a neutropenic state (30, 31) . Furthermore, a variety of widely used drugs are associated with decreases in neutrophil counts (31) . It can reasonably be assumed that patients with neutropenia-inducing diseases or with the need to take such drugs were likely to have been included in the Q1 group. These confounding factors may be among the causes of the somewhat poorer prognosis of Q1. Another potential confounding factor would be the effects of lifestyle habits which are strongly related to general cancer risk. NLR reportedly has a positive association with smoking (32) and pickled food intake (33) , as well as a negative association with obesity (34) . NLR might reflect such lifestyle-related factors and have a bidirectional relationship with general susceptibility to cancer development, in addition to its actual positive association with recurrence as noted in several past publications (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Our database employed in this study does not provide sufficient information on these lifestyle-related factors, such that the roles of these factors remain speculative. Among our future tasks, we plan to obtain more information on factors possibly showing associations with NLR.
Our study has limitations. First, missing variables and selection bias are possible due to the uncontrolled and retrospective nature of this investigation, though most of our patient population (97.4%) had precise data available for the preoperative NLR. Second, most participants in this study were ethnically Japanese and hence the results may not be generalizable to other populations. Third, inflammatory markers such as NLR could be influenced by a wide range of systemic diseases. Despite our efforts to avoid biases (for example, by excluding patients with synchronous malignancies, hematological disorders, liver cirrhosis, inflammatory diseases and/ or collagen diseases), it is difficult to completely avoid false positive/ negative cases.
The optimal methodology for NLR stratification has yet to be determined. Nonetheless, we believe that our observations provide useful insights for future research focusing on this area. Further prospective studies with multicenter data will be needed before any definitive conclusions can be drawn.
Conclusion
We performed a retrospective analysis assessing the prognostic value of preoperative NLR, dividing gastric cancer patients according to the quartiles of NLR. Although preoperative NLR was found to be independently associated with OS and RFS in multivariate Cox regression analysis, a comparison between each pair of the four groups did not indicate a monophasic linear pattern, rather indicating a J-shaped pattern. We should keep in mind this methodological limitation when analyzing prognostic values of NLR in patients with gastric cancer.
